

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | valine metabolic process (GO:0006573) | 5.24092657 |
| 2 | oxaloacetate metabolic process (GO:0006107) | 4.78080985 |
| 3 | response to peptidoglycan (GO:0032494) | 4.71949785 |
| 4 | cellular response to type I interferon (GO:0071357) | 4.44847155 |
| 5 | type I interferon signaling pathway (GO:0060337) | 4.44847155 |
| 6 | response to type I interferon (GO:0034340) | 4.39633771 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 4.36926378 |
| 8 | 2-oxoglutarate metabolic process (GO:0006103) | 4.34290209 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.24117240 |
| 10 | lysine catabolic process (GO:0006554) | 4.23939820 |
| 11 | lysine metabolic process (GO:0006553) | 4.23939820 |
| 12 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.16679859 |
| 13 | NIK/NF-kappaB signaling (GO:0038061) | 4.06327906 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.04022296 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.04022296 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.03903184 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.96629367 |
| 18 | cysteine metabolic process (GO:0006534) | 3.95841230 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 3.93581401 |
| 20 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.86029872 |
| 21 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.83557659 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 3.82167274 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.82167274 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.78186665 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.78186665 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.78186665 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 3.78186665 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 3.78186665 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.78186665 |
| 30 | carnitine shuttle (GO:0006853) | 3.73692025 |
| 31 | mannose metabolic process (GO:0006013) | 3.73232410 |
| 32 | defense response to protozoan (GO:0042832) | 3.71964205 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 3.71839314 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.67664971 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.67664971 |
| 36 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.65315496 |
| 37 | germinal center formation (GO:0002467) | 3.65043922 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.62477252 |
| 39 | detection of other organism (GO:0098543) | 3.62127797 |
| 40 | glycine metabolic process (GO:0006544) | 3.58779250 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.58532955 |
| 42 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.57040250 |
| 43 | response to protozoan (GO:0001562) | 3.56700612 |
| 44 | detection of bacterium (GO:0016045) | 3.53683145 |
| 45 | regulation of interferon-alpha production (GO:0032647) | 3.51956425 |
| 46 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.49861895 |
| 47 | L-phenylalanine catabolic process (GO:0006559) | 3.49763483 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.49763483 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 3.48483951 |
| 50 | tricarboxylic acid metabolic process (GO:0072350) | 3.47404345 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.47377255 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.45919899 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 3.45875140 |
| 54 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.44424207 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.44403748 |
| 56 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.43989436 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 3.43650453 |
| 58 | negative regulation of sterol transport (GO:0032372) | 3.43650453 |
| 59 | positive regulation of type 2 immune response (GO:0002830) | 3.43404427 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.41575359 |
| 61 | myeloid dendritic cell differentiation (GO:0043011) | 3.38394431 |
| 62 | biotin metabolic process (GO:0006768) | 3.36829692 |
| 63 | succinate metabolic process (GO:0006105) | 3.36089538 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 3.35020740 |
| 65 | carnitine transport (GO:0015879) | 3.33801866 |
| 66 | amino-acid betaine transport (GO:0015838) | 3.33801866 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33119077 |
| 68 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.31241678 |
| 69 | positive regulation of histone deacetylation (GO:0031065) | 3.31115411 |
| 70 | ribosomal small subunit assembly (GO:0000028) | 3.30924906 |
| 71 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.29777909 |
| 72 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.26523816 |
| 73 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.24041045 |
| 74 | carnitine transmembrane transport (GO:1902603) | 3.23147807 |
| 75 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.21836767 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.18996845 |
| 77 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18840828 |
| 78 | creatine metabolic process (GO:0006600) | 3.18702883 |
| 79 | nucleotide salvage (GO:0043173) | 3.18593530 |
| 80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17279126 |
| 81 | regulation of chronic inflammatory response (GO:0002676) | 3.16554743 |
| 82 | positive regulation of interferon-alpha production (GO:0032727) | 3.13972282 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 3.13556134 |
| 84 | branched-chain amino acid metabolic process (GO:0009081) | 3.10053359 |
| 85 | regulation of vitamin metabolic process (GO:0030656) | 3.09373002 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 3.08036220 |
| 87 | leukocyte aggregation (GO:0070486) | 3.06857864 |
| 88 | carnitine metabolic process (GO:0009437) | 3.05930364 |
| 89 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.05463114 |
| 90 | regulation of chemokine biosynthetic process (GO:0045073) | 3.05410119 |
| 91 | detection of external biotic stimulus (GO:0098581) | 3.05243676 |
| 92 | aspartate family amino acid catabolic process (GO:0009068) | 3.05223098 |
| 93 | regulation of type 2 immune response (GO:0002828) | 3.05108983 |
| 94 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.04719620 |
| 95 | purine nucleotide salvage (GO:0032261) | 3.04480145 |
| 96 | regulation of antigen processing and presentation (GO:0002577) | 3.03048200 |
| 97 | regulation of podosome assembly (GO:0071801) | 3.03036620 |
| 98 | myeloid dendritic cell activation (GO:0001773) | 3.02368511 |
| 99 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.01846166 |
| 100 | aromatic amino acid family catabolic process (GO:0009074) | 2.99508008 |
| 101 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.98519520 |
| 102 | homocysteine metabolic process (GO:0050667) | 2.98161599 |
| 103 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.97731650 |
| 104 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.95260118 |
| 105 | kynurenine metabolic process (GO:0070189) | 2.94442151 |
| 106 | detection of molecule of bacterial origin (GO:0032490) | 2.94082507 |
| 107 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93646063 |
| 108 | fatty acid homeostasis (GO:0055089) | 2.93047376 |
| 109 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92992967 |
| 110 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.92859015 |
| 111 | Peyers patch development (GO:0048541) | 2.92859015 |
| 112 | nuclear pore complex assembly (GO:0051292) | 2.92278788 |
| 113 | quaternary ammonium group transport (GO:0015697) | 2.90782012 |
| 114 | IMP biosynthetic process (GO:0006188) | 2.88784170 |
| 115 | regulation of T cell tolerance induction (GO:0002664) | 2.88627243 |
| 116 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.87458847 |
| 117 | myeloid cell activation involved in immune response (GO:0002275) | 2.87457431 |
| 118 | fructose metabolic process (GO:0006000) | 2.85952841 |
| 119 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.85755698 |
| 120 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.85686239 |
| 121 | NADH metabolic process (GO:0006734) | 2.85683210 |
| 122 | regulation of T-helper cell differentiation (GO:0045622) | 2.85630826 |
| 123 | fatty acid oxidation (GO:0019395) | 2.83816657 |
| 124 | T cell migration (GO:0072678) | 2.82577042 |
| 125 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.82494263 |
| 126 | 4-hydroxyproline metabolic process (GO:0019471) | 2.82469466 |
| 127 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.82452434 |
| 128 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.82381771 |
| 129 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81689128 |
| 130 | urea metabolic process (GO:0019627) | 2.80818552 |
| 131 | urea cycle (GO:0000050) | 2.80818552 |
| 132 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.80173744 |
| 133 | alpha-amino acid catabolic process (GO:1901606) | 2.79240329 |
| 134 | cellular response to interferon-gamma (GO:0071346) | 2.79194778 |
| 135 | negative regulation of lipid transport (GO:0032369) | 2.78718884 |
| 136 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.78175221 |
| 137 | drug transmembrane transport (GO:0006855) | 2.78096471 |
| 138 | fatty acid beta-oxidation (GO:0006635) | 2.77207758 |
| 139 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.76854185 |
| 140 | cellular modified amino acid catabolic process (GO:0042219) | 2.76155316 |
| 141 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.76087354 |
| 142 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.75666150 |
| 143 | lipid oxidation (GO:0034440) | 2.74744838 |
| 144 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73963831 |
| 145 | one-carbon metabolic process (GO:0006730) | 2.73921010 |
| 146 | high-density lipoprotein particle remodeling (GO:0034375) | 2.73755167 |
| 147 | macrophage activation (GO:0042116) | 2.73537356 |
| 148 | IMP metabolic process (GO:0046040) | 2.72292826 |
| 149 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.71540868 |
| 150 | activation of MAPKKK activity (GO:0000185) | 2.70328987 |
| 151 | nitrogen cycle metabolic process (GO:0071941) | 2.70076724 |
| 152 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.69353416 |
| 153 | cellular amino acid catabolic process (GO:0009063) | 2.69302040 |
| 154 | detection of biotic stimulus (GO:0009595) | 2.68762166 |
| 155 | negative regulation of viral genome replication (GO:0045071) | 2.68203576 |
| 156 | dendritic cell differentiation (GO:0097028) | 2.68091431 |
| 157 | negative regulation of innate immune response (GO:0045824) | 2.67604069 |
| 158 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.67545699 |
| 159 | positive regulation of nuclease activity (GO:0032075) | 2.67295921 |
| 160 | embryonic placenta development (GO:0001892) | 2.66651466 |
| 161 | granulocyte activation (GO:0036230) | 2.65422412 |
| 162 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.65273627 |
| 163 | regulation of interleukin-12 production (GO:0032655) | 2.64748327 |
| 164 | cellular response to lipopolysaccharide (GO:0071222) | 2.63766976 |
| 165 | mature B cell differentiation involved in immune response (GO:0002313) | 2.63352218 |
| 166 | regulation of tolerance induction (GO:0002643) | 2.63157041 |
| 167 | maternal placenta development (GO:0001893) | 2.62532856 |
| 168 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.62121726 |
| 169 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.61497310 |
| 170 | positive regulation of interferon-beta production (GO:0032728) | 2.61490304 |
| 171 | pentose-phosphate shunt (GO:0006098) | 2.61487356 |
| 172 | response to interferon-gamma (GO:0034341) | 2.60949628 |
| 173 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.60432449 |
| 174 | response to host immune response (GO:0052572) | 2.60432449 |
| 175 | tryptophan catabolic process (GO:0006569) | 2.60328230 |
| 176 | indole-containing compound catabolic process (GO:0042436) | 2.60328230 |
| 177 | indolalkylamine catabolic process (GO:0046218) | 2.60328230 |
| 178 | ketone body metabolic process (GO:1902224) | 2.59956509 |
| 179 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.59777693 |
| 180 | cellular response to molecule of bacterial origin (GO:0071219) | 2.59273600 |
| 181 | regulation of necroptotic process (GO:0060544) | 2.56474214 |
| 182 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.56337374 |
| 183 | regulation of triglyceride catabolic process (GO:0010896) | 2.56092140 |
| 184 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.54660063 |
| 185 | short-chain fatty acid metabolic process (GO:0046459) | 2.54564477 |
| 186 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.54511006 |
| 187 | negative regulation of interleukin-6 production (GO:0032715) | 2.54185365 |
| 188 | modulation by symbiont of host cellular process (GO:0044068) | 2.54120225 |
| 189 | galactose catabolic process (GO:0019388) | 2.53585682 |
| 190 | tryptophan metabolic process (GO:0006568) | 2.52769032 |
| 191 | cellular response to osmotic stress (GO:0071470) | 2.51747623 |
| 192 | urate metabolic process (GO:0046415) | 2.49732593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.29568623 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.62690884 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60853685 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.34237835 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.10435055 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.07917249 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.95536390 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69614182 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.67168993 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.63638347 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.54269856 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39415884 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28383860 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27348154 |
| 15 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.21916006 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20573544 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15047630 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13341726 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.03809638 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.99035308 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.98726025 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.97666104 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97388118 |
| 24 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.89997772 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.83198284 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.80381312 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78980593 |
| 28 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.76356376 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75895022 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.75718081 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74382412 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70500742 |
| 33 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67174551 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66680024 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66418704 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63483890 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58788840 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.58565967 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.56054561 |
| 40 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.55078709 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52725763 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.52101181 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51174175 |
| 44 | * MAF_26560356_Chip-Seq_TH2_Human | 1.51013969 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50413453 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49550307 |
| 47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46001067 |
| 48 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45874481 |
| 49 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.45029971 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44634350 |
| 51 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44352300 |
| 52 | * P68_20966046_ChIP-Seq_HELA_Human | 1.44202482 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43244987 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42752678 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41333971 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40909995 |
| 57 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.40804228 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40672636 |
| 59 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38799590 |
| 60 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37340807 |
| 61 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36302905 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36263506 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33769440 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32741807 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.32507313 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32034965 |
| 67 | MYB_26560356_Chip-Seq_TH1_Human | 1.31203058 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30805394 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30150803 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29784118 |
| 71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27601173 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27485542 |
| 73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27237125 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27184427 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27137793 |
| 76 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.27091646 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25863676 |
| 78 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.25601189 |
| 79 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.25185215 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25061682 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23359221 |
| 82 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.22775704 |
| 83 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22611479 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22320983 |
| 85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21843117 |
| 86 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19564755 |
| 87 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19200357 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18935129 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17791510 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17509935 |
| 91 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17436545 |
| 92 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16951005 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16297752 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16030627 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15897993 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15298972 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12907972 |
| 98 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.12717444 |
| 99 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12440310 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12396955 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12164636 |
| 102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11953201 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11508503 |
| 104 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10481271 |
| 105 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09313172 |
| 106 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08469591 |
| 107 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07668036 |
| 108 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.05938129 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04860755 |
| 110 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03718984 |
| 111 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03253776 |
| 112 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03220629 |
| 113 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02687876 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02568004 |
| 115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02223029 |
| 116 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01833818 |
| 117 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01175610 |
| 118 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00355260 |
| 119 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99535959 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99088486 |
| 121 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.99018896 |
| 122 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98653760 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98210386 |
| 124 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98073682 |
| 125 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97970894 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97885481 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97767154 |
| 128 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97614363 |
| 129 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97505052 |
| 130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97493217 |
| 131 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96775517 |
| 132 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96615902 |
| 133 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96305537 |
| 134 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.96072695 |
| 135 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95574777 |
| 136 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.94988703 |
| 137 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.94574734 |
| 138 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.93174552 |
| 139 | MYB_26560356_Chip-Seq_TH2_Human | 0.92329049 |
| 140 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.91275774 |
| 141 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90744381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.98342321 |
| 2 | MP0003724_increased_susceptibility_to | 3.67277035 |
| 3 | MP0006082_CNS_inflammation | 3.58548352 |
| 4 | MP0003283_abnormal_digestive_organ | 3.57446570 |
| 5 | MP0005360_urolithiasis | 3.40368815 |
| 6 | MP0009840_abnormal_foam_cell | 3.30634577 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.28207998 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.13227735 |
| 9 | MP0009785_altered_susceptibility_to | 3.00683320 |
| 10 | MP0003252_abnormal_bile_duct | 2.95735226 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.93109591 |
| 12 | MP0005365_abnormal_bile_salt | 2.86585342 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.83836838 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.73483359 |
| 15 | MP0003303_peritoneal_inflammation | 2.69935254 |
| 16 | MP0002419_abnormal_innate_immunity | 2.49879621 |
| 17 | MP0009278_abnormal_bone_marrow | 2.45486920 |
| 18 | MP0003646_muscle_fatigue | 2.33971246 |
| 19 | MP0005671_abnormal_response_to | 2.33745367 |
| 20 | MP0002723_abnormal_immune_serum | 2.18760717 |
| 21 | MP0001545_abnormal_hematopoietic_system | 2.17260161 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 2.17260161 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.11135097 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 2.10024741 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.09132704 |
| 26 | MP0002396_abnormal_hematopoietic_system | 2.01030725 |
| 27 | MP0002909_abnormal_adrenal_gland | 2.00108508 |
| 28 | MP0004947_skin_inflammation | 1.98893247 |
| 29 | MP0003075_altered_response_to | 1.98665677 |
| 30 | MP0010329_abnormal_lipoprotein_level | 1.95033138 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.90970676 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.90892093 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.90310830 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.89674324 |
| 35 | MP0001819_abnormal_immune_cell | 1.89625987 |
| 36 | MP0002254_reproductive_system_inflammat | 1.89445715 |
| 37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.86030489 |
| 38 | MP0004130_abnormal_muscle_cell | 1.84680843 |
| 39 | MP0004510_myositis | 1.83415495 |
| 40 | MP0009764_decreased_sensitivity_to | 1.75317526 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.72664741 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.69940961 |
| 43 | MP0005332_abnormal_amino_acid | 1.69849614 |
| 44 | MP0002405_respiratory_system_inflammati | 1.68408661 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.63034315 |
| 46 | MP0003690_abnormal_glial_cell | 1.62104715 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.61995735 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.60995627 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.58919756 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.58790817 |
| 51 | MP0003868_abnormal_feces_composition | 1.57651527 |
| 52 | MP0000609_abnormal_liver_physiology | 1.57300174 |
| 53 | MP0000343_altered_response_to | 1.51217596 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.47322447 |
| 55 | MP0002118_abnormal_lipid_homeostasis | 1.46313254 |
| 56 | MP0005166_decreased_susceptibility_to | 1.43668212 |
| 57 | MP0009672_abnormal_birth_weight | 1.42985657 |
| 58 | MP0000858_altered_metastatic_potential | 1.41565407 |
| 59 | MP0000716_abnormal_immune_system | 1.41550020 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.40834007 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.40735580 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.37183261 |
| 63 | MP0008004_abnormal_stomach_pH | 1.36958953 |
| 64 | MP0001873_stomach_inflammation | 1.36054445 |
| 65 | MP0003693_abnormal_embryo_hatching | 1.35797857 |
| 66 | MP0005220_abnormal_exocrine_pancreas | 1.34877891 |
| 67 | MP0008260_abnormal_autophagy | 1.34317274 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.31330124 |
| 69 | MP0004019_abnormal_vitamin_homeostasis | 1.31296834 |
| 70 | MP0003448_altered_tumor_morphology | 1.30255261 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.27414295 |
| 72 | MP0004043_abnormal_pH_regulation | 1.27327767 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.26111141 |
| 74 | MP0005451_abnormal_body_composition | 1.24295105 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 1.22103910 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 1.21589129 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.21463066 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 1.21122933 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 1.17391891 |
| 80 | MP0002693_abnormal_pancreas_physiology | 1.15735062 |
| 81 | MP0000747_muscle_weakness | 1.13937776 |
| 82 | MP0005334_abnormal_fat_pad | 1.12270214 |
| 83 | MP0003195_calcinosis | 1.11952265 |
| 84 | MP0005083_abnormal_biliary_tract | 1.11682364 |
| 85 | MP0002166_altered_tumor_susceptibility | 1.11563342 |
| 86 | MP0005164_abnormal_response_to | 1.09719630 |
| 87 | MP0002429_abnormal_blood_cell | 1.08892364 |
| 88 | MP0001765_abnormal_ion_homeostasis | 1.08601912 |
| 89 | MP0003866_abnormal_defecation | 1.04469642 |
| 90 | MP0005375_adipose_tissue_phenotype | 1.03682704 |
| 91 | MP0003566_abnormal_cell_adhesion | 1.02194637 |
| 92 | MP0005464_abnormal_platelet_physiology | 0.99939427 |
| 93 | MP0000598_abnormal_liver_morphology | 0.99677040 |
| 94 | MP0001663_abnormal_digestive_system | 0.98661048 |
| 95 | MP0002933_joint_inflammation | 0.98030915 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.97751489 |
| 97 | MP0004883_abnormal_blood_vessel | 0.97698755 |
| 98 | MP0001851_eye_inflammation | 0.97475490 |
| 99 | MP0005390_skeleton_phenotype | 0.96164078 |
| 100 | MP0003828_pulmonary_edema | 0.95694674 |
| 101 | MP0001853_heart_inflammation | 0.95200198 |
| 102 | MP0004036_abnormal_muscle_relaxation | 0.95141170 |
| 103 | MP0000685_abnormal_immune_system | 0.94568255 |
| 104 | MP0005330_cardiomyopathy | 0.92269320 |
| 105 | MP0003091_abnormal_cell_migration | 0.91738360 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.90910369 |
| 107 | MP0003436_decreased_susceptibility_to | 0.90807429 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.90646898 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89888998 |
| 110 | MP0005310_abnormal_salivary_gland | 0.89514760 |
| 111 | MP0009763_increased_sensitivity_to | 0.89509219 |
| 112 | MP0010630_abnormal_cardiac_muscle | 0.88907326 |
| 113 | MP0008469_abnormal_protein_level | 0.88304815 |
| 114 | MP0005647_abnormal_sex_gland | 0.87174376 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.86376547 |
| 116 | MP0003329_amyloid_beta_deposits | 0.86352022 |
| 117 | MP0000689_abnormal_spleen_morphology | 0.86185479 |
| 118 | MP0002019_abnormal_tumor_incidence | 0.85627969 |
| 119 | MP0008874_decreased_physiological_sensi | 0.83917917 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.83558435 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.83259552 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.82904444 |
| 123 | MP0005670_abnormal_white_adipose | 0.82848536 |
| 124 | MP0002132_abnormal_respiratory_system | 0.82571244 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.81953531 |
| 126 | MP0008057_abnormal_DNA_replication | 0.81800373 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.81092244 |
| 128 | MP0001764_abnormal_homeostasis | 0.80366311 |
| 129 | MP0000920_abnormal_myelination | 0.80306817 |
| 130 | MP0001800_abnormal_humoral_immune | 0.79586747 |
| 131 | MP0000490_abnormal_crypts_of | 0.78165194 |
| 132 | MP0002398_abnormal_bone_marrow | 0.78075390 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.78002471 |
| 134 | MP0005387_immune_system_phenotype | 0.76991858 |
| 135 | MP0001790_abnormal_immune_system | 0.76991858 |
| 136 | MP0001756_abnormal_urination | 0.76603765 |
| 137 | MP0005023_abnormal_wound_healing | 0.76309420 |
| 138 | MP0000249_abnormal_blood_vessel | 0.75713687 |
| 139 | MP0005535_abnormal_body_temperature | 0.75192997 |
| 140 | MP0002269_muscular_atrophy | 0.74734101 |
| 141 | MP0010307_abnormal_tumor_latency | 0.74358877 |
| 142 | MP0005165_increased_susceptibility_to | 0.73885818 |
| 143 | MP0005025_abnormal_response_to | 0.73207721 |
| 144 | MP0009642_abnormal_blood_homeostasis | 0.73142068 |
| 145 | MP0002971_abnormal_brown_adipose | 0.72545369 |
| 146 | MP0005410_abnormal_fertilization | 0.72451533 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.71464224 |
| 148 | MP0000703_abnormal_thymus_morphology | 0.71414787 |
| 149 | MP0000604_amyloidosis | 0.70453991 |
| 150 | MP0003279_aneurysm | 0.67722879 |
| 151 | MP0004087_abnormal_muscle_fiber | 0.67334933 |
| 152 | MP0005076_abnormal_cell_differentiation | 0.65808627 |
| 153 | MP0003806_abnormal_nucleotide_metabolis | 0.65617681 |
| 154 | MP0002086_abnormal_extraembryonic_tissu | 0.65538487 |
| 155 | MP0002722_abnormal_immune_system | 0.65188203 |
| 156 | MP0003045_fibrosis | 0.64240213 |
| 157 | MP0000538_abnormal_urinary_bladder | 0.64056732 |
| 158 | MP0001542_abnormal_bone_strength | 0.63552335 |
| 159 | MP0006054_spinal_hemorrhage | 0.62244716 |
| 160 | MP0005381_digestive/alimentary_phenotyp | 0.60366730 |
| 161 | MP0003795_abnormal_bone_structure | 0.59530192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.81021191 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.81021191 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.81021191 |
| 4 | Orchitis (HP:0100796) | 4.60205492 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.56221931 |
| 6 | Myositis (HP:0100614) | 4.52077158 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.45789836 |
| 8 | Optic neuritis (HP:0100653) | 4.43881532 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.43881532 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.40479125 |
| 11 | Hyperglycinuria (HP:0003108) | 4.21873637 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.15778999 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.97652707 |
| 14 | Stomatitis (HP:0010280) | 3.95796907 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.60906792 |
| 16 | Loss of speech (HP:0002371) | 3.53392364 |
| 17 | Hyperammonemia (HP:0001987) | 3.42084461 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.34376187 |
| 19 | Hyperglycinemia (HP:0002154) | 3.29604796 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 3.25511311 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.25511311 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.24848249 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.20100334 |
| 24 | Gout (HP:0001997) | 3.16654055 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.14480556 |
| 26 | Increased IgE level (HP:0003212) | 3.13262303 |
| 27 | Vasculitis (HP:0002633) | 3.10505034 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.09804215 |
| 29 | Ketosis (HP:0001946) | 2.99481758 |
| 30 | Prolonged bleeding time (HP:0003010) | 2.98837799 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.97828403 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.97828403 |
| 33 | Impaired platelet aggregation (HP:0003540) | 2.96478439 |
| 34 | Abnormal platelet function (HP:0011869) | 2.96478439 |
| 35 | Hyperlipoproteinemia (HP:0010980) | 2.96183363 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.94851546 |
| 37 | Ketoacidosis (HP:0001993) | 2.92821053 |
| 38 | Asymmetric septal hypertrophy (HP:0001670) | 2.92186000 |
| 39 | Recurrent skin infections (HP:0001581) | 2.89158476 |
| 40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.87301169 |
| 41 | Obstructive lung disease (HP:0006536) | 2.84476370 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84476370 |
| 43 | Pili torti (HP:0003777) | 2.80743373 |
| 44 | Sensorimotor neuropathy (HP:0007141) | 2.80727980 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.80578887 |
| 46 | Meningitis (HP:0001287) | 2.80192372 |
| 47 | Abnormality of the thoracic spine (HP:0100711) | 2.79818030 |
| 48 | Abnormal hair laboratory examination (HP:0003328) | 2.78993342 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.78721951 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.78371149 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.78371149 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.78371149 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.78119608 |
| 54 | High anterior hairline (HP:0009890) | 2.75563307 |
| 55 | Nuclear cataract (HP:0100018) | 2.75133709 |
| 56 | Polycythemia (HP:0001901) | 2.73684823 |
| 57 | Disinhibition (HP:0000734) | 2.73554340 |
| 58 | Nasal polyposis (HP:0100582) | 2.72806522 |
| 59 | Joint hemorrhage (HP:0005261) | 2.71886927 |
| 60 | Xanthomatosis (HP:0000991) | 2.71605984 |
| 61 | Deep venous thrombosis (HP:0002625) | 2.69666356 |
| 62 | Myoglobinuria (HP:0002913) | 2.68086393 |
| 63 | Gingivitis (HP:0000230) | 2.67661060 |
| 64 | Amyloidosis (HP:0011034) | 2.65653392 |
| 65 | Recurrent viral infections (HP:0004429) | 2.64753995 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.64211962 |
| 67 | Neurofibrillary tangles (HP:0002185) | 2.63524697 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.62473040 |
| 69 | Spastic diplegia (HP:0001264) | 2.62464283 |
| 70 | Back pain (HP:0003418) | 2.61626219 |
| 71 | Thrombocytosis (HP:0001894) | 2.60077499 |
| 72 | Gastrointestinal stroma tumor (HP:0100723) | 2.55924979 |
| 73 | Bundle branch block (HP:0011710) | 2.55857985 |
| 74 | Hemoptysis (HP:0002105) | 2.52770685 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.52232148 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.52199878 |
| 77 | Neuronal loss in central nervous system (HP:0002529) | 2.51210722 |
| 78 | Mutism (HP:0002300) | 2.50388420 |
| 79 | Axonal loss (HP:0003447) | 2.50084605 |
| 80 | Colitis (HP:0002583) | 2.50041607 |
| 81 | Late onset (HP:0003584) | 2.49191735 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48667597 |
| 83 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.47424909 |
| 84 | Increased IgM level (HP:0003496) | 2.46583162 |
| 85 | Glomerulonephritis (HP:0000099) | 2.46310844 |
| 86 | Ragged-red muscle fibers (HP:0003200) | 2.45884089 |
| 87 | Abnormality of the nasal mucosa (HP:0000433) | 2.45149162 |
| 88 | Encephalitis (HP:0002383) | 2.42622160 |
| 89 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.42124877 |
| 90 | Rhabdomyolysis (HP:0003201) | 2.42098721 |
| 91 | Gangrene (HP:0100758) | 2.40667015 |
| 92 | Visual hallucinations (HP:0002367) | 2.37946016 |
| 93 | Hypobetalipoproteinemia (HP:0003563) | 2.37596422 |
| 94 | Purpura (HP:0000979) | 2.36239615 |
| 95 | Epidermoid cyst (HP:0200040) | 2.34022845 |
| 96 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33536287 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 2.33536287 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 2.33536135 |
| 99 | Exercise-induced myalgia (HP:0003738) | 2.32223771 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31401335 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31401335 |
| 102 | Supranuclear gaze palsy (HP:0000605) | 2.28356096 |
| 103 | Cellulitis (HP:0100658) | 2.28168728 |
| 104 | Arterial thrombosis (HP:0004420) | 2.24164447 |
| 105 | Urticaria (HP:0001025) | 2.23893948 |
| 106 | Ventricular tachycardia (HP:0004756) | 2.23611435 |
| 107 | Myocardial infarction (HP:0001658) | 2.23200304 |
| 108 | Abnormality of nucleobase metabolism (HP:0010932) | 2.22739084 |
| 109 | Neoplasm of the oral cavity (HP:0100649) | 2.22579157 |
| 110 | Atrioventricular block (HP:0001678) | 2.20389995 |
| 111 | Spontaneous hematomas (HP:0007420) | 2.20324460 |
| 112 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14523028 |
| 113 | Subacute progressive viral hepatitis (HP:0006572) | 2.14166516 |
| 114 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.13661041 |
| 115 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13423578 |
| 116 | Global brain atrophy (HP:0002283) | 2.11478574 |
| 117 | Episodic fever (HP:0001954) | 2.11413942 |
| 118 | Polygenic inheritance (HP:0010982) | 2.09859771 |
| 119 | Emphysema (HP:0002097) | 2.09713431 |
| 120 | Cerebral inclusion bodies (HP:0100314) | 2.09248426 |
| 121 | Abnormality of the fingertips (HP:0001211) | 2.09210911 |
| 122 | Pulmonary embolism (HP:0002204) | 2.08558510 |
| 123 | Autoimmune hemolytic anemia (HP:0001890) | 2.07756132 |
| 124 | Abnormality of complement system (HP:0005339) | 2.06583960 |
| 125 | Acne (HP:0001061) | 2.06573796 |
| 126 | Intrahepatic cholestasis (HP:0001406) | 2.05699239 |
| 127 | Petechiae (HP:0000967) | 2.05520983 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 2.05390465 |
| 129 | Hepatocellular carcinoma (HP:0001402) | 2.04816069 |
| 130 | Progressive muscle weakness (HP:0003323) | 2.04549303 |
| 131 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.04511346 |
| 132 | Exercise-induced muscle cramps (HP:0003710) | 2.03971685 |
| 133 | Abnormal number of erythroid precursors (HP:0012131) | 2.03492777 |
| 134 | Heart block (HP:0012722) | 2.03063590 |
| 135 | Pustule (HP:0200039) | 2.02508126 |
| 136 | Limb hypertonia (HP:0002509) | 2.02202290 |
| 137 | Hypolipoproteinemia (HP:0010981) | 2.01712766 |
| 138 | Menorrhagia (HP:0000132) | 2.00962223 |
| 139 | Hypochromic anemia (HP:0001931) | 2.00738552 |
| 140 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.00320772 |
| 141 | Slow saccadic eye movements (HP:0000514) | 2.00131284 |
| 142 | Hyperuricemia (HP:0002149) | 1.97738875 |
| 143 | Increased purine levels (HP:0004368) | 1.97738875 |
| 144 | Colon cancer (HP:0003003) | 1.96988756 |
| 145 | Restrictive lung disease (HP:0002091) | 1.96915316 |
| 146 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.96167934 |
| 147 | Hypoalphalipoproteinemia (HP:0003233) | 1.95477649 |
| 148 | Long toe (HP:0010511) | 1.94770153 |
| 149 | Hematochezia (HP:0002573) | 1.94241685 |
| 150 | Polyneuropathy (HP:0001271) | 1.93753474 |
| 151 | Hemiplegia (HP:0002301) | 1.93751657 |
| 152 | Glomerulopathy (HP:0100820) | 1.93244178 |
| 153 | Abnormality of the pleura (HP:0002103) | 1.93204212 |
| 154 | Hypoglycemic coma (HP:0001325) | 1.92764410 |
| 155 | Progressive neurologic deterioration (HP:0002344) | 1.92248982 |
| 156 | Chest pain (HP:0100749) | 1.92216657 |
| 157 | Cubitus valgus (HP:0002967) | 1.92193210 |
| 158 | Basal ganglia calcification (HP:0002135) | 1.91274937 |
| 159 | Dysmetric saccades (HP:0000641) | 1.91204635 |
| 160 | Epistaxis (HP:0000421) | 1.91180049 |
| 161 | Vertigo (HP:0002321) | 1.90807843 |
| 162 | Apathy (HP:0000741) | 1.89829199 |
| 163 | Parakeratosis (HP:0001036) | 1.89597344 |
| 164 | Anorexia (HP:0002039) | 1.89457704 |
| 165 | Prolonged partial thromboplastin time (HP:0003645) | 1.88178237 |
| 166 | Increased serum ferritin (HP:0003281) | 1.87916364 |
| 167 | Papilloma (HP:0012740) | 1.86980329 |
| 168 | Verrucae (HP:0200043) | 1.86980329 |
| 169 | Abnormality of the Achilles tendon (HP:0005109) | 1.84254761 |
| 170 | Gastrointestinal inflammation (HP:0004386) | 1.83395978 |
| 171 | IgM deficiency (HP:0002850) | 1.83245976 |
| 172 | Inflammation of the large intestine (HP:0002037) | 1.81757188 |
| 173 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.79978476 |
| 174 | Neonatal onset (HP:0003623) | 1.78966372 |
| 175 | Malnutrition (HP:0004395) | 1.76040979 |
| 176 | Abnormal atrioventricular conduction (HP:0005150) | 1.75849385 |
| 177 | Dysostosis multiplex (HP:0000943) | 1.75817441 |
| 178 | Ulnar deviation of the wrist (HP:0003049) | 1.74637188 |
| 179 | Meningioma (HP:0002858) | 1.74522666 |
| 180 | Ulnar bowing (HP:0003031) | 1.74105689 |
| 181 | Metabolic acidosis (HP:0001942) | 1.73939436 |
| 182 | Complement deficiency (HP:0004431) | 1.73307438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.86270378 |
| 2 | PRPF4B | 3.50830267 |
| 3 | PKN2 | 3.39705137 |
| 4 | ICK | 3.38257331 |
| 5 | PRKD2 | 2.84865127 |
| 6 | BRD4 | 2.79147959 |
| 7 | MAP3K14 | 2.74433944 |
| 8 | RIPK1 | 2.54438069 |
| 9 | LATS1 | 2.34905758 |
| 10 | TAOK2 | 2.32365402 |
| 11 | ERN1 | 2.13558098 |
| 12 | BLK | 2.10655356 |
| 13 | MAP3K13 | 2.04457567 |
| 14 | IKBKE | 2.01920264 |
| 15 | MAP2K3 | 2.01481894 |
| 16 | TAOK3 | 1.93517766 |
| 17 | PTK6 | 1.88297135 |
| 18 | MAP4K1 | 1.86656060 |
| 19 | MAP3K10 | 1.86158501 |
| 20 | CSK | 1.79973730 |
| 21 | GRK6 | 1.79899933 |
| 22 | PINK1 | 1.77684184 |
| 23 | GRK7 | 1.74382549 |
| 24 | TAOK1 | 1.70493490 |
| 25 | BCKDK | 1.70045713 |
| 26 | KSR2 | 1.66405177 |
| 27 | EEF2K | 1.64526990 |
| 28 | IKBKB | 1.62307081 |
| 29 | TTN | 1.57060177 |
| 30 | NME2 | 1.56206977 |
| 31 | PDK4 | 1.53648260 |
| 32 | PDK3 | 1.53648260 |
| 33 | MAP3K2 | 1.51188558 |
| 34 | NEK2 | 1.50537542 |
| 35 | BMX | 1.45876025 |
| 36 | FGR | 1.43014571 |
| 37 | CDK4 | 1.42858505 |
| 38 | DDR2 | 1.40934006 |
| 39 | PRKCH | 1.40093824 |
| 40 | JAK3 | 1.36470502 |
| 41 | FES | 1.34978320 |
| 42 | SIK3 | 1.34343542 |
| 43 | MATK | 1.33767557 |
| 44 | CDC42BPA | 1.32128406 |
| 45 | IRAK3 | 1.30421431 |
| 46 | NTRK3 | 1.23423255 |
| 47 | TXK | 1.21907919 |
| 48 | MAP3K6 | 1.21718525 |
| 49 | PDPK1 | 1.21514987 |
| 50 | STK11 | 1.20567094 |
| 51 | PDK1 | 1.19698713 |
| 52 | MOS | 1.18058719 |
| 53 | IRAK2 | 1.16419171 |
| 54 | SIK2 | 1.15323972 |
| 55 | TGFBR2 | 1.14593103 |
| 56 | PIM1 | 1.13896033 |
| 57 | BMPR2 | 1.13280891 |
| 58 | MAP3K1 | 1.11248084 |
| 59 | SIK1 | 1.10433096 |
| 60 | RAF1 | 1.09101861 |
| 61 | MAP3K7 | 1.08484991 |
| 62 | JAK2 | 1.05810946 |
| 63 | LRRK2 | 1.05639296 |
| 64 | BTK | 1.03346161 |
| 65 | STK38 | 1.01776673 |
| 66 | CSNK1A1L | 0.91838023 |
| 67 | MAP3K11 | 0.90937154 |
| 68 | PIM2 | 0.90363351 |
| 69 | LYN | 0.89259466 |
| 70 | MARK2 | 0.88069774 |
| 71 | CSNK1G1 | 0.86632017 |
| 72 | CSNK1G3 | 0.85915802 |
| 73 | MST1R | 0.85410342 |
| 74 | TNK2 | 0.84671681 |
| 75 | CAMKK1 | 0.82703129 |
| 76 | FLT3 | 0.82149414 |
| 77 | EPHB1 | 0.81248680 |
| 78 | ALK | 0.80075751 |
| 79 | ZAP70 | 0.78726987 |
| 80 | SYK | 0.78534581 |
| 81 | CHUK | 0.78119061 |
| 82 | TYK2 | 0.77721227 |
| 83 | CAMK1D | 0.77704944 |
| 84 | RIPK4 | 0.77625777 |
| 85 | MTOR | 0.75866977 |
| 86 | IRAK1 | 0.75431570 |
| 87 | LCK | 0.75232304 |
| 88 | FGFR4 | 0.70367547 |
| 89 | MAPK12 | 0.70000289 |
| 90 | TIE1 | 0.69566139 |
| 91 | MAPK7 | 0.68745322 |
| 92 | STK10 | 0.67360534 |
| 93 | GSK3A | 0.67079931 |
| 94 | RET | 0.67024142 |
| 95 | ITK | 0.66644998 |
| 96 | MAP3K8 | 0.65462019 |
| 97 | HIPK2 | 0.64761814 |
| 98 | CDK7 | 0.63564159 |
| 99 | SCYL2 | 0.63416337 |
| 100 | DAPK2 | 0.63226142 |
| 101 | CSNK1G2 | 0.62318626 |
| 102 | TYRO3 | 0.62168738 |
| 103 | MAPK4 | 0.61549551 |
| 104 | IRAK4 | 0.59846176 |
| 105 | MAP3K3 | 0.59750354 |
| 106 | CAMKK2 | 0.59376272 |
| 107 | KIT | 0.59251901 |
| 108 | CDK6 | 0.58446839 |
| 109 | CSF1R | 0.56951153 |
| 110 | PRKD3 | 0.56759622 |
| 111 | SMG1 | 0.56630791 |
| 112 | PRKAA1 | 0.56207609 |
| 113 | CDK12 | 0.55541944 |
| 114 | TESK1 | 0.53762806 |
| 115 | HCK | 0.51486256 |
| 116 | RPS6KC1 | 0.50044852 |
| 117 | RPS6KL1 | 0.50044852 |
| 118 | PRKAA2 | 0.49212697 |
| 119 | CAMK1G | 0.48710535 |
| 120 | ARAF | 0.47566978 |
| 121 | SGK3 | 0.47306971 |
| 122 | PDK2 | 0.46853000 |
| 123 | MARK3 | 0.46673212 |
| 124 | TBK1 | 0.46658525 |
| 125 | PKN1 | 0.44897757 |
| 126 | NUAK1 | 0.44104354 |
| 127 | ABL2 | 0.43298078 |
| 128 | EPHA3 | 0.40527710 |
| 129 | RPS6KA1 | 0.39662205 |
| 130 | JAK1 | 0.39552967 |
| 131 | MUSK | 0.39197718 |
| 132 | FGFR3 | 0.38664555 |
| 133 | DMPK | 0.37860116 |
| 134 | MAPK11 | 0.36167202 |
| 135 | WNK4 | 0.35367908 |
| 136 | FRK | 0.34923544 |
| 137 | RPS6KA6 | 0.34490790 |
| 138 | MAP2K6 | 0.33914670 |
| 139 | RPS6KB1 | 0.32980433 |
| 140 | BRSK2 | 0.32796855 |
| 141 | FYN | 0.32030513 |
| 142 | SGK1 | 0.31359417 |
| 143 | DYRK1B | 0.30606890 |
| 144 | PDGFRA | 0.29776832 |
| 145 | RPS6KA2 | 0.29249946 |
| 146 | MAP3K5 | 0.29073274 |
| 147 | PRKCQ | 0.28471583 |
| 148 | MAPKAPK2 | 0.28160982 |
| 149 | PAK6 | 0.27818916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21380754 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.07958783 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76019726 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67064301 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.66173110 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.63636819 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62381328 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.60145232 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.27955947 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.26967763 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24214645 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.17686817 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17680317 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.17441607 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.15907833 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.06007980 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05200062 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.03395320 |
| 19 | Malaria_Homo sapiens_hsa05144 | 2.03287092 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.99933360 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.96561636 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95221461 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.90290577 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.89459835 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.86129675 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.83771566 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.83224242 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.78446077 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.77919412 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.76858023 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74988372 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74684384 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71954462 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.70910198 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69551712 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67132766 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66310044 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65052851 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.63605132 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.63344168 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.62376314 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.59405345 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58974047 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.56113841 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.53692645 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50939001 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48733604 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48601773 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.48399865 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44640914 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43839604 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41119767 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 1.40047851 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39361723 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.38051901 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 1.35527670 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34620118 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.32721786 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 1.32450287 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 1.31948849 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31781695 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 1.29963525 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29533184 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28904151 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27847392 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27544033 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27167507 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.27006045 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25895132 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25169133 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 1.24786277 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24545764 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24022705 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.23658816 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23320756 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22578449 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21153257 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20856651 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20333925 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18453258 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17148820 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 1.14493949 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11004007 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08476769 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.07280216 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.05581342 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05362815 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02439582 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 1.00977609 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00812883 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00002586 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.97621304 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94076612 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93629752 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93448029 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93255912 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.92745147 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91874135 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89979536 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89140685 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.88815322 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86248989 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.86136906 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85682320 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85140092 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83585511 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83568547 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83549607 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79803479 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.79527236 |
| 111 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78206716 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76933362 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75470657 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73768456 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71784758 |
| 116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71730839 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71577158 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67394961 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.65568020 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63471977 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63073147 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63065009 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61556009 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61111213 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57830084 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57107004 |
| 127 | DNA replication_Homo sapiens_hsa03030 | 0.56385965 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.55434171 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55325865 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54204430 |
| 131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53238522 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52581361 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51425480 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51320686 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50583260 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49550325 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.49301620 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.47578443 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46704008 |
| 140 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46096724 |
| 141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46081144 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44578982 |
| 143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44462168 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42722959 |
| 145 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42453968 |
| 146 | Ribosome_Homo sapiens_hsa03010 | 0.41870496 |
| 147 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41611565 |
| 148 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39106527 |
| 149 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37467209 |
| 150 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36792966 |
| 151 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35949076 |
| 152 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35404471 |
| 153 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34788562 |
| 154 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34512879 |
| 155 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34056576 |
| 156 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33328501 |
| 157 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32997723 |
| 158 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32985960 |
| 159 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32946962 |
| 160 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32831597 |
| 161 | Insulin secretion_Homo sapiens_hsa04911 | 0.32199195 |
| 162 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31795666 |
| 163 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31226469 |
| 164 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.30619486 |
| 165 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30310643 |
| 166 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30025326 |
| 167 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29181809 |
| 168 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28736832 |
| 169 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25715260 |
| 170 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25117110 |
| 171 | Prion diseases_Homo sapiens_hsa05020 | 0.24569391 |
| 172 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.18919235 |

